{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Eligible",
      "product_code": "NVQ",
      "openfda": {
        "k_number": [
          "K051794",
          "K143592"
        ],
        "registration_number": [
          "1050190"
        ],
        "fei_number": [
          "1050190"
        ]
      },
      "review_panel": "MI",
      "medical_specialty": "MI",
      "device_name": "Bacteriophage And Controls, B. Anthracis Lysis",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "Microbiology",
      "device_class": "2",
      "definition": "A gamma phage lysis assay intended for the identification of bacillus anthracis from non-hemolytic, aerobic gram positive colonies isolated from sheep blood agar.  To aid in the laboratory identification of bacillus anthracis culture growth by lysis with a specific bacteriophage.",
      "regulation_number": "866.3045",
      "implant_flag": "N",
      "submission_type_id": "1"
    }
  ]
}